Best Insurance Stocks in India 2026: Life Margins Hold at 24.7-27.9% as IRDAI Commission Rules Loom

shubham-chaudhary Best Insurance Stocks in India 2026: Life Margins Hold at 24.7-27.9% as IRDAI Commission Rules Loom
Written & researched by Finance Analyst & Founder, PositionalCalls
  • Updated:
  • Sources: NSE, BSE, SEBI & company filings
  • How we research
LinkedIn

Insurance · Insurance Stocks

Looking for the best insurance stocks in India 2026? This page compares five listed insurers on the metric each is judged by, using Q2 FY27 results as reported, and tracks the IRDAI distribution draft. It names no winner.

Updated: Sunday, 15 November 2026, 8:33 AM IST  |  Reading time: 18 min  |  Next update: on final IRDAI rules or the Q3 FY27 results

Quick answer

The best insurance stocks in India 2026 cannot be ranked on one number, because life insurers are read on VNB margin and general and health insurers on combined ratio. H1 FY27 VNB margins were HDFC Life 24.7%, SBI Life 27.9% and ICICI Life 26.0%; Star Health reported a 98.0% ratio.

27.9%SBI Life H1 FY27 VNB margin
+22.3%ICICI Life H1 FY27 VNB growth
107.0%ICICI Lombard Q2 combined ratio, headline figure
98.0%Star Health Q2 combined insurance service ratio
31 OctIRDAI feedback deadline after extension

Latest update (Sunday, 15 November 2026, 8:33 AM IST): Rebuilt on Q2 FY27 results for all five insurers and on IRDAI’s extension of its feedback deadline to 31 October. One earlier figure is corrected: HDFC Life’s embedded value, which the sources I opened put at Rs 66,461 crore. HDFC Life’s 24.5% Q2 margin from the earlier version is restored, because PL Capital reports it, up 39 basis points a year on year. ICICI Prudential Life is reported as ICICI Life Insurance, formerly ICICI Prudential Life.

Key takeaways

  • No ranking: this page compares five insurers on stated criteria. It gives no rating, target or buy list.
  • Life insurers: H1 FY27 VNB margins were HDFC Life 24.7%, SBI Life 27.9% and ICICI Life 26.0%, with VNB growth of 12.1%, about 19% and 22.3%.
  • General and health: ICICI Lombard’s Q2 combined ratio was 107.0% as the headline figure; Star Health reported a 98.0% combined insurance service ratio and an underwriting profit of Rs 99 crore.
  • IRDAI: the distribution draft is not final. Feedback closed on 31 October after more than 650 responses, and a Bloomberg-based report says another consultation is expected before final rules.
  • Gaps: no live prices, no price-to-embedded-value data, no flow data, and no exchange filing opened in this rebuild.

In plain words: VNB margin shows how profitable newly sold life policies are expected to be. Combined ratio shows claims plus expenses as a share of premium; above 100% means an underwriting loss before investment income. The two cannot be compared with each other.

Data note: Life insurer and Star Health figures are from news and results summaries of company releases: Kotak Neo, Upstox, SAHI, Free Press Journal, Cafemutual, Compounding AI and UNI. ICICI Lombard figures and SBI Life’s Q1 inputs are carried from the 26 October version of this page, which cited an NSE filing for ICICI Lombard; its profit is cross-checked to SAHI. I opened no exchange filing in this rebuild, so confirm each figure against the company filing.

best-insurance-stocks-in-india-2026-vnb-margin-h1-fy27 Best Insurance Stocks in India 2026: Life Margins Hold at 24.7-27.9% as IRDAI Commission Rules Loom
H1 FY27 VNB margin and VNB growth, three listed life insurers. Source: company results as reported by Kotak Neo, Upstox and SAHI.

1. What are the best insurance stocks in India 2026?

There is no single list of the best insurance stocks in India 2026 that one number can produce. These five are the large listed insurers most readers track, and each is read on a different scorecard, so this page compares and does not rank.

HDFC Life, SBI Life and ICICI Life are life insurers. ICICI Lombard is a general insurer and Star Health is a health insurer. ICICI Life is the company formerly named ICICI Prudential Life; the Free Press Journal reports the new name and gives no date for the change. All five have reported Q2 FY27 (July to September 2026), but life insurers published half-year figures and some quarter-only numbers are missing, so the periods below differ.

Insurer Type Period Key figures What it tells you
HDFC Life Life H1 FY27 (Apr-Sep 2026); Q2 reported 15 Oct VNB Rs 2,037 crore (+12.1%); VNB margin 24.7% (24.5% a year earlier); APE Rs 8,245 crore (+11%); embedded value Rs 66,461 crore Margin edged up; growth is the slowest of the three life insurers
SBI Life Life H1 FY27; reported by 27 Oct VNB Rs 3,270 crore (+19%); VNB margin 27.9%; APE Rs 11,750 crore (+18%); solvency 1.97 Highest margin of the three, with costs rising
ICICI Life Life Q2 FY27 and H1 FY27; board approval 13 Oct Q2 VNB Rs 712 crore (+20.7%), margin 25.43%; H1 VNB Rs 1,283 crore (+22.3%), margin 26.0%; solvency 229.9% Fastest VNB growth; Q2 margin missed some analyst estimates
ICICI Lombard General Q2 FY27; filed 14 Oct Combined ratio 107.0% (headline); profit after tax Rs 946 crore (+15.5%); premium growth 3.0% against industry 7.0% Underwriting loss before investment income
Star Health Health Q2 FY27; announced 29 Oct Combined insurance service ratio 98.0% (100.9% a year earlier); underwriting profit Rs 99 crore; reported profit Rs 265 crore; GWP Rs 5,275 crore (+19%) Underwriting profit for a fifth quarter, but reported profit fell from Q1

Cite this table: Company results as reported by Kotak Neo, Upstox, SAHI, Free Press Journal, UNI and the 26 October version of this page; originals not opened; periods and metrics differ by row.

Advertisement

Rows are not like for like. A life insurer’s VNB margin and a general insurer’s combined ratio measure different things, and the ICICI Lombard ratio differs by accounting basis, so the row shows the headline figure. The next sections set out each company’s numbers with the source and the caveat.

2. What changed in the best insurance stocks in India 2026 page since 26 October?

This rebuild replaces first-quarter figures with half-year or Q2 figures for the life insurers, adds Star Health’s Q2 result and the IRDAI deadline extension, and corrects two HDFC Life numbers that the sources I opened do not support.

What the best insurance stocks in India 2026 page corrected and dropped

Item 26 October version This rebuild Why
HDFC Life VNB margin 24.5% for Q2 FY27 24.5% for Q2 FY27 (restored); 24.7% for H1 FY27 PL Capital reports a Q2 margin of 24.5%, up 39 basis points; Kotak Neo gives H1 24.7%, up from 24.5% a year earlier. The Q2 figure rests on one brokerage note and I did not open the filing
HDFC Life embedded value Rs 65,860 crore Rs 66,461 crore Kotak Neo and Cafemutual both give Rs 66,461 crore
HDFC Life solvency 180% Not shown Neither source I opened gives a solvency ratio
SBI Life Q1 FY27 margin 26.2% H1 FY27 margin 27.9%; Q2-only figures derived Half-year results are out
ICICI Prudential Life Q1 FY27 margin 26.7% Q2 margin 25.43%; H1 26.0% Q2 results are out; company reported as ICICI Life Insurance
Star Health Q1 FY27 ratio 97.7% Q2 FY27 ratio 98.0% Q2 results announced 29 October
IRDAI deadline 25 October, no extension confirmed Extended to 31 October Reported 26 October with more than 650 responses
GST, penetration and a premium-fall claim Included from a broker note and a presentation Dropped I could not re-check them; they are not carried over

Cite this table: Comparison of the 26 October PositionalCalls version with sources opened in this rebuild; originals not opened.

The pattern is that the earlier page leaned on two single numbers that the later sources do not repeat. I removed those and kept only figures that at least one source I opened states, labelling anything I derived as my calculation.

3. Life insurers: HDFC Life, SBI Life and ICICI Life

On H1 FY27 numbers the three life insurers sit in a 24.7% to 27.9% VNB margin band. ICICI Life grew VNB fastest at 22.3%, SBI Life earned the highest margin, and HDFC Life grew the slowest, so the best insurance stocks in India 2026 question depends on whether you weigh margin or growth.

H1 FY27 (Apr-Sep 2026) HDFC Life SBI Life ICICI Life
VNB Rs 2,037 crore (+12.1%) Rs 3,270 crore (+19%) Rs 1,283 crore (+22.3%)
APE Rs 8,245 crore (+11%) Rs 11,750 crore (+18%) Rs 4,935 crore (+15.1%)
VNB margin 24.7% (24.5% a year earlier) 27.9% (27.8% a year earlier) 26.0%
Profit after tax Rs 1,119 crore (+12.7%) Rs 1,270 crore (+17%) Rs 760 crore (+26.5%)
Embedded value Rs 66,461 crore Rs 87,350 crore Not found
Solvency Not found 1.97 (1.94 a year earlier) 229.9% (213.2% a year earlier)
Check: VNB divided by APE (my calculation) 24.7% 27.8% 26.0%

Cite this table: H1 data as reported by Kotak Neo, Cafemutual, Compounding AI, Upstox, SAHI and Free Press Journal; originals not opened. The last row is my division of the reported VNB by APE.

Advertisement

The check row matters. Dividing reported VNB by APE gives 24.7% for HDFC Life, 27.8% for SBI Life and 26.0% for ICICI Life, which agree with the reported margins within rounding. That gives me confidence in the three margins even though I did not open the filings.

HDFC Life

  • Growth picked up: Q2 VNB rose 14.8% and Q2 APE rose 13%, against 9% APE growth in Q1.
  • Return: the rolling 12-month operating return on embedded value was 14.9%.
  • Cost and persistency: the H1 expense ratio rose to 22.3% from 21.6%, and 13th-month persistency fell to 83% from 86%, while 61st-month persistency rose to 66% from 62%.
  • Scale: assets under management were Rs 4.10 lakh crore, up 14%.

HDFC Life is the slowest grower of the three on VNB, and its higher expense ratio and lower 13th-month persistency are the two numbers a reader would want to see recover. PL Capital puts the Q2-only margin at 24.5%, up 39 basis points a year on year (single source, filing not opened); neither source I opened gave a solvency ratio.

SBI Life

  • Margin: 27.9% for H1 FY27 against 27.8% a year earlier. Q1 was 26.2% on figures carried from the earlier page (VNB Rs 1,410 crore on APE Rs 5,380 crore).
  • Costs: the operating expense ratio rose to 6.9% from 6.2% and the total cost ratio to 11.7% from 10.9%.
  • Persistency: 13th-month persistency was 85.82% and 61st-month persistency 58.01%.
  • Return: return on equity was 12.9%, up from 12.3%.

Subtracting Q1 from H1 implies a Q2 VNB of about Rs 1,860 crore on APE of about Rs 6,370 crore, a margin near 29.2% (my calculation). That chain mixes sources and rounded inputs, so treat it as indicative. It also implies Q2 APE growth well below Q1’s 36%, which the half-year APE growth of 18% supports. Management guidance for FY27 margin was 26% to 28%, per the earlier version of this page; H1 sits at the top of that range. Compounding AI reported that SBI Life did not disclose a margin in the filing summary it used, while Kotak Neo gave 27.9%, and my division gives 27.8%.

ICICI Life Insurance

  • Q2: VNB Rs 712 crore (+20.7%), APE Rs 2,799 crore (+16.6%), margin 25.43%, profit Rs 374.22 crore (+24.8%).
  • Versus estimates: Nomura said the 25.4% margin missed its 26.7% estimate, while SAHI put the street estimate at 25.79%; the reports differ.
  • Mix: Bernstein and Goldman Sachs credited product mix, with protection, annuities and the partnership channel; Jefferies said a higher group funds mix held the margin below expectations and cut its FY27 to FY29 VNB estimates by 2%.
  • Margin change: one report puts the year-earlier margin at 24%; JP Morgan said the margin rose about 100 bps. I could not reconcile the two.

Q2 VNB of Rs 712 crore plus Q1’s Rs 571 crore from the earlier page equals the reported H1 figure of Rs 1,283 crore, a useful consistency check (my calculation). The Q2 margin of 25.43% is below Q1’s 26.7%, so the half-year 26.0% hides a sequential fall.

4. General and health insurers: ICICI Lombard and Star Health

ICICI Lombard and Star Health are read on combined ratio. ICICI Lombard reported 107.0% as the headline figure, an underwriting loss, while Star Health reported a combined insurance service ratio of 98.0% and an underwriting profit of Rs 99 crore, but its reported profit fell from Q1.

Advertisement
Item ICICI Lombard Q2 FY27 Star Health Q2 FY27
Underwriting ratio Combined ratio 107.0% (headline); 104.5% (other basis) Combined insurance service ratio 98.0% (100.9% a year earlier)
Profit after tax Rs 946 crore (+15.5%); Rs 1,031 crore on the other basis Reported Rs 265 crore (+233%); normalised Rs 390 crore (+70%)
Premium growth GDPI +3.0% against industry +7.0% Gross written premium Rs 5,275 crore (+19%, 1/N)
Underwriting result Loss before investment income Profit Rs 99 crore, against a loss of Rs 40 crore a year earlier
Capital Solvency 2.75x (minimum 1.50x) Not found
Claims signal Health loss ratio 85.3% against 77.3% a year earlier Q2 claims ratio not found

Cite this table: ICICI Lombard figures carried from the 26 October version, which cited the 14 October NSE filing; its Rs 946 crore profit and Rs 820 crore year-earlier figure also appear in SAHI. Star Health per UNI/PR Newswire, 29 October 2026; originals not opened.

The two bases for ICICI Lombard differ by 2.5 percentage points (107.0% minus 104.5%, my calculation), and the sources I opened do not say which accounting basis each pair uses, so I have not labelled them. This page uses the 107.0% headline figure.

PositionalCalls WhatsApp channel

Follow insurer results plainly

  • Quarterly insurer results in plain words
  • Explainers on VNB and combined ratio
  • A message when this page is updated

Star Health’s reported profit of Rs 265 crore is about 52% below Q1’s Rs 550 crore (my calculation), while the combined ratio was 97.7% in Q1 on the earlier basis and 98.0% in Q2 on the new one. The two ratios are not on identical bases, and I found no source explaining the profit gap. The company’s normalised profit of Rs 390 crore uses an assumed 8% investment yield, so it is a company measure and not an accounting profit.

5. The IRDAI distribution reset and the best insurance stocks in India 2026

IRDAI’s 23 September 2026 consultation paper, “Recalibrating Economics of Insurance Distribution”, is still a draft. Feedback closed on 31 October after an extension, and final rules had not appeared in my searches as of 15 November 2026.

Date Event Status
23 Sep 2026 IRDAI consultation paper proposes lower expense limits and new commission rules Draft
24 Sep 2026 Listed insurer and distributor shares fall; PB Fintech reported down 36% in a day Reported
9 Oct 2026 Inc42, citing Bloomberg, reports IRDAI is considering 1 January or 1 April 2027 for commission caps Under consideration
25 Oct 2026 Original feedback deadline Passed
31 Oct 2026 Extended deadline; more than 650 submissions reported on 26 October Closed
Next Inc42 reports IRDAI will review feedback and publish draft regulations for another consultation before final rules Not yet seen

Cite this table: Events as reported by Inc42, SAHI and YourStory headlines; IRDAI primary documents not opened; the Bloomberg interview is reported second-hand.

The draft’s main proposals, carried from the earlier page and reported rather than checked against the paper, are lower life insurer expense limits (15% of gross direct premium within two years and 12.5% within five), commission limits tied to segment, product, channel and effort, no volume-linked incentives for bank and NBFC staff, and clawback of commission for mis-selling. A separate paper reportedly proposes a five-year transition for insurer expense limits, with the first interim milestone in FY29.

The Insurance Brokers Association of India warned of a 60% to 70% revenue hit for brokers and asked for the deadline to move to the end of December, per Inc42. HDFC Life, SBI Life and ICICI Life depend heavily on bank-partner channels, so the bank-staff incentive proposal is the item to watch; the effect on each insurer cannot be sized from public numbers I found.

Advertisement

6. How life, general and health insurers make money

Insurers collect premiums first, pay claims later and invest the float in between. Life, general and health insurers are judged on different metrics, which is why the best insurance stocks in India 2026 cannot be sorted on a single column.

Term Meaning Where it matters
VNB Value of new business written in a period Life insurers
APE Annualised premium equivalent, the standard measure of new life business Life insurers
VNB margin VNB divided by APE Life insurers
Embedded value Value of the in-force book plus net assets Life insurers; used with price for valuation
Persistency Share of policies still paying after 13 or 61 months Life insurers; signals quality of sales
Combined ratio Claims plus expenses as a share of premium General and health insurers
Solvency ratio Available capital against the regulatory minimum (1.50x) All insurers

Cite this table: Definitions by PositionalCalls; no source needed beyond the company disclosures.

Worked check (my calculation) Arithmetic Result
HDFC Life H1 FY27 margin Rs 2,037 crore divided by Rs 8,245 crore 24.7%, matches the reported margin
SBI Life H1 FY27 margin Rs 3,270 crore divided by Rs 11,750 crore 27.8%, against 27.9% reported
ICICI Life Q2 FY27 margin Rs 712 crore divided by Rs 2,799 crore 25.4%, matches the reported 25.43%
ICICI Life H1 FY27 margin Rs 1,283 crore divided by Rs 4,935 crore 26.0%, matches the reported margin
ICICI Lombard accounting gap 107.0% minus 104.5% 2.5 percentage points

Cite this table: Division of reported figures by PositionalCalls; inputs as reported by the sources named above.

The worked checks are not a verification of the filings, only evidence that the reported numbers are internally consistent. Where a margin could not be divided, such as HDFC Life’s Q2, I did not state one.

7. How to compare the best insurance stocks in India 2026 on the same criteria

Use the same checks for every insurer, and read each from the company filing for the same period. The table below shows which check applies to which type of insurer, and where the evidence on this page is thin.

  • Same period: compare quarter with quarter or half-year with half-year, and note the as-of date.
  • Right metric: VNB margin and APE growth for life; combined ratio, premium growth against the industry and claims for general and health.
  • Stated basis: n or 1/n for ICICI Lombard; normalised or reported profit for Star Health.
  • Capital: solvency ratio against the regulatory minimum.
  • Regulatory exposure: bank-channel dependence and product mix.
  • Valuation inputs: a live price from NSE or BSE and the company embedded value disclosure; this page gives no valuation verdict.
Factor Life insurer General insurer Health insurer
Main profit metric VNB margin Combined ratio Combined ratio
Policy term Long term Mostly one year Mostly one year, renewable
Common swing factor Product mix, persistency, rules Catastrophe, motor and health claims Claims inflation, retail mix
Evidence on this page H1 FY27 for three insurers One quarter, headline ratio One quarter, normalised and reported profit
Missing here Q2-only margin for one, valuation Industry share, valuation Claims ratio, valuation

Cite this table: Framework by PositionalCalls; evidence column reflects the sources opened in this rebuild.

If you want valuation, the usual life insurer check is price to embedded value, and for general and health insurers price to earnings alongside the combined ratio. I did not collect live prices for this rebuild, so the page offers no multiple and no view on whether any of these stocks is cheap or expensive.

Advertisement

8. What are the risks and common mistakes with the best insurance stocks in India 2026?

The main risks are draft IRDAI rules, rising costs and weaker persistency, claims and accounting swings at general and health insurers, and a product mix that can shift margins either way within a quarter.

Draft IRDAI rulesExpense limits and commission caps could change distribution costs; final rules may differ, and a second consultation is expected.
Costs and persistencyHDFC Life’s H1 expense ratio rose to 22.3% from 21.6%; SBI Life’s operating expense ratio rose to 6.9% from 6.2%; HDFC Life’s 13th-month persistency fell to 83% from 86%.
ClaimsICICI Lombard’s Q2 health loss ratio was 85.3% against 77.3%, and its Q1 profit fell 46% to Rs 403 crore.
Reported profit swingsStar Health’s reported profit fell from Rs 550 crore in Q1 to Rs 265 crore in Q2, and I found no explanation.
Product mixICICI Life’s margin moved with protection, annuity and group funds mix; Jefferies cut estimates on mix.
Data gapsNo live price or flow data, and no reported Q2-only margin for SBI Life.

Common mistakes:

  • Quoting a margin without its period, such as setting a Q2 margin beside an H1 one.
  • Comparing a life insurer’s VNB margin with a general insurer’s combined ratio.
  • Ignoring the accounting basis behind a ratio.
  • Treating normalised profit as reported profit.
  • Reading a draft regulation as a final rule.

9. How to invest in insurance stocks in India: what you need and what it costs

You need a demat and trading account with a SEBI-registered broker. Charges and tax depend on your broker and current rules, and shares of an insurer are different from an insurance policy.

PositionalCalls is not SEBI registered, so nothing here is a recommendation to buy or sell. Read the results filing first and check any listed company on NSE or BSE.

10. What to watch next for the best insurance stocks in India 2026

Five items would change this picture: the IRDAI draft regulations and any second consultation, Q3 FY27 results, persistency and expense ratios at the life insurers, claims at ICICI Lombard and Star Health, and valuation data once live prices are added.

Watch item A stronger reading A weaker reading
IRDAI regulations Final rules close to the draft limits with a long transition Caps start on 1 January 2027 with little transition
Life insurer margins H1 margins hold at or above current levels Q3 margins fall on mix or cost
Persistency and expenses 13th-month persistency recovers; expense ratios stop rising Persistency keeps falling
General insurer claims Combined ratio moves toward 100% Loss ratios keep rising
Star Health profit Reported profit recovers toward Q1’s level Reported profit stays below normalised profit

Cite this table: Watch list by PositionalCalls; these are conditions to check, not forecasts or probabilities.

This is a checklist, not a forecast. I assign no probability and no target to any item, and I found no confirmed Q3 FY27 result dates.

11. What most people miss, and how to check

  • What stands out: the three life insurers sit in a narrow 24.7% to 27.9% margin band, so growth, costs and channel exposure may matter more than margin alone.
  • Easy to miss: the accounting basis moves ICICI Lombard’s combined ratio by 2.5 points, and Star Health’s normalised profit is 47% above its reported profit (my calculation).
  • What would change the picture: final IRDAI rules and Q3 FY27 results.
  • Reader action: open each company’s results release on NSE or BSE and recompute the metric before relying on it.

Reasoning from the data above; not a forecast.

  1. Match the metric to the insurer: VNB margin for life, combined ratio for general and health.
  2. Match the period: a half-year margin is not a quarter margin.
  3. Divide the numbers yourself: VNB over APE takes a minute and catches typos.
  4. Check the basis: 1/n or n, normalised or reported.
  5. Read the regulation status: draft, second consultation or final.

For the cover side of insurance see my term insurance plans and health insurance plans guides.

Bottom line

The best insurance stocks in India 2026 cannot be ranked on one number. Life insurers held VNB margins of 24.7% to 27.9% in H1 FY27, ICICI Life grew VNB fastest, ICICI Lombard ran a 107.0% combined ratio and Star Health a 98.0% ratio. The biggest open item is IRDAI’s distribution draft. Check the same-period figures yourself.

Next read: capital gains tax on shares

Part of the Insurance series on PositionalCalls. Sector view: insurance sector outlook 2026.

PositionalCalls WhatsApp channel

Keep IRDAI changes in one place

  • A dated note when IRDAI rules move
  • Insurer results as they come
  • Updates when new data is out

FAQs on the best insurance stocks in India 2026

What are the best insurance stocks in India 2026?

There is no single best. HDFC Life, SBI Life, ICICI Life, ICICI Lombard and Star Health are the large listed names compared here, each judged on VNB margin or combined ratio. The best insurance stocks in India 2026 depend on your criteria, so compare the company filings and not a ranking.

Which are the best life insurance stocks in India for the long term?

A long-term view depends on your goals and on data that changes every quarter. For life insurers, check VNB margin, APE growth, embedded value, persistency and solvency in each filing, and the final IRDAI rules. In H1 FY27 VNB margins were HDFC Life 24.7%, SBI Life 27.9% and ICICI Life 26.0%.

Life insurance vs general insurance stocks India: what is the difference?

Life insurers sell long-term policies and are read on VNB margin and embedded value. General and health insurers sell mostly one-year policies and are read on combined ratio, claims and premium growth. Catastrophe and claims swings matter more for general insurers, so the two groups need different scorecards.

How to invest in insurance stocks India?

Insurance stocks are bought through a demat and trading account with a SEBI-registered broker after KYC. Read the results filing first, check brokerage and tax charges with your broker, and remember these are listed company shares, not insurance policies. PositionalCalls is not SEBI registered and gives no buy or sell advice.

Who grew faster among the best insurance stocks in India 2026?

Among the life insurers covered, ICICI Life reported H1 FY27 VNB growth of 22.3%, SBI Life about 19% and HDFC Life 12.1%. SBI Life had the highest margin at 27.9%. Growth and margin are different measures, so this is a comparison of reported figures, not a ranking or a recommendation.

What is the IRDAI distribution consultation paper?

On 23 September 2026 IRDAI proposed lower expense limits and new commission rules in a paper called Recalibrating Economics of Insurance Distribution. Feedback closed on 31 October after an extension, with more than 650 responses reported. It is a draft, and I found no final regulations as of 15 November 2026.

Are insurance stocks cheap in 2026?

This page gives no valuation verdict, because valuation depends on live prices that I did not collect. Life insurers are usually checked on price to embedded value using the company disclosure, and general insurers on earnings and combined ratio. Check live prices on NSE or BSE before drawing any conclusion.

What are VNB margin and combined ratio?

VNB margin is value of new business divided by APE: HDFC Life’s H1 FY27 Rs 2,037 crore on Rs 8,245 crore gives about 24.7%. Combined ratio is claims plus expenses as a share of premium; above 100% means an underwriting loss before investment income, as with ICICI Lombard’s 107.0% in Q2 FY27.

How did Star Health and ICICI Lombard do in Q2 FY27?

ICICI Lombard reported a 107.0% combined ratio as the headline figure and profit after tax of Rs 946 crore. Star Health reported a 98.0% combined insurance service ratio, an underwriting profit of Rs 99 crore and reported profit of Rs 265 crore, against Rs 550 crore in Q1. Both bases differ, so compare with care.

Does this page say which insurance stock to buy?

No. This page names no stock to buy and gives no rating or target, so it is not a buy list of the best insurance stocks in India 2026. It reports company and regulatory data and says where data is missing, such as valuation and flows. Read the filings and consider a registered adviser before investing.

Sources

shubham-chaudhary Best Insurance Stocks in India 2026: Life Margins Hold at 24.7-27.9% as IRDAI Commission Rules Loom
Written & researched by Finance Analyst & Founder, PositionalCalls

Shubham Chaudhary is the founder of PositionalCalls, an independent Indian stock market research website. He writes company fundamentals, quarterly results analysis, IPO analysis and sector research for NSE and BSE listed companies, with a focus on banking stocks, insurance and long-term value investing. Every article is built from primary sources such as RBI, SEBI, NSE and BSE filings and company annual reports, and states its risks plainly in simple language for retail investors.

Coverage areas Our research standards
  • Numbers checked against NSE, BSE and SEBI filings
  • Risks and limits stated in every article
  • No paid promotions or broker tie-ups
  • Articles updated when new filings arrive
Disclosure: The author is not a SEBI-registered investment adviser. Content is for education and information only and is not investment advice. Investments are subject to market risks. Consult a SEBI-registered adviser before investing.

Leave a comment